1. Ultragenyx and Kyowa Kirin’s Crysvita (burosumab) Receive the US FDA’s Approval for the Treatment of Tumor-Induced Osteomalacia Published: Jun 19, 2020 | Tags: Ultragenyx, Kyowa Kirin, Crysvita, burosumab, Receives, US, […]readmore
Tags : MassBio
Shots: The launch of Bayer-MassCONNECT Asia will support the startup community in Asia with a special focus on China. The collaboration of two companies will integrate MassBio’s mentoring expertise with […]readmore